相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
Etienne Garin et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Lung shunt and lung dose calculation methods for radioembolization treatment planning
S. Cheenu Kappadath et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Reassessment of the lung dose limits for radioembolization
S. Cheenu Kappadath et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort
Arighno Das et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Calculation of lung mean dose and quantification of error for 90Y-microsphere radioembolization using 99mTc-MAA SPECT/CT and diagnostic chest CT
Benjamin Lopez et al.
MEDICAL PHYSICS (2019)
Fast and accurate quantitative determination of the lung shunt fraction in hepatic radioembolization
Remco Bastiaannet et al.
PHYSICS IN MEDICINE AND BIOLOGY (2019)
Radioembolisation in Europe: A Survey Amongst CIRSE Members
Margot T. M. Reinders et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver Tumors
Helmut Dittmann et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study
Jonathan D. Allred et al.
EJNMMI RESEARCH (2018)
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet S. Wasan et al.
LANCET ONCOLOGY (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Pharmacokinetics of 99mTc-MAA- and 99mTc-HSA-Microspheres Used in Preradioembolization Dosimetry: Influence on the Liver-Lung Shunt
Oliver S. Grosser et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres
Mattijs Elschot et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
Yung Hsiang Kao et al.
EJNMMI RESEARCH (2014)
Influence of Time Delay on the Estimated Lung Shunt Fraction on 99mTc-Labeled MAA Scintigraphy for 90Y Microsphere Treatment Planning
Ruth De Gersem et al.
CLINICAL NUCLEAR MEDICINE (2013)
Lung Dose Calculation With SPECT/CT for 90Yittrium Radioembolization of Liver Cancer
Naichang Yu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
IMAGE QUANTIFICATION FOR RADIATION DOSE CALCULATIONS-LIMITATIONS AND UNCERTAINTIES
J. M. Pereira et al.
HEALTH PHYSICS (2010)
Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung Distribution
Riad Salem et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
分享论文
